Mai Anh, Nowotarski Shannon L
Penn State Berks, 212D Luerssen Building, Reading, PA, 19610, USA.
Methods Mol Biol. 2018;1694:299-308. doi: 10.1007/978-1-4939-7398-9_25.
Ornithine decarboxylase (ODC) is the first rate-limiting enzyme in the polyamine biosynthetic pathway. It has been well documented that ODC is tightly regulated at the levels of transcription, posttranscriptional changes in RNA, and protein degradation during normal conditions and that these processes are dysregulated during tumorigenesis. Moreover, it has been recently shown that ODC is posttranscriptionally regulated by RNA binding proteins (RBPs) which can bind to the ODC mRNA transcript and alter its stability and translation. Using a mouse skin cancer model, we show that the RBP human antigen R (HuR) is able to bind to synthetic mRNA transcripts through a pulldown assay which utilizes a biotin-labeled ODC 3'-untranslated region (UTR). The details of this method are described here. A better understanding of the mechanism(s) which regulates ODC is critical for targeting ODC in chemoprevention.
鸟氨酸脱羧酶(ODC)是多胺生物合成途径中的首个限速酶。已有充分文献记载,在正常情况下,ODC在转录水平、RNA的转录后变化以及蛋白质降解过程中受到严格调控,而在肿瘤发生过程中这些过程会失调。此外,最近研究表明,ODC受到RNA结合蛋白(RBP)的转录后调控,这些蛋白可与ODC mRNA转录本结合并改变其稳定性和翻译。利用小鼠皮肤癌模型,我们通过下拉实验表明RBP人类抗原R(HuR)能够与合成mRNA转录本结合,该实验利用了生物素标记的ODC 3'-非翻译区(UTR)。本文描述了该方法的详细信息。更好地理解调节ODC的机制对于在化学预防中靶向ODC至关重要。